BIRC5 and metastatic melanoma: For instance, reports evaluated the efficacy of a vaccine where DCs were transfected with survivin mRNA or TERT tumor antigen mRNA along with silencing indoleamine 2,3-dioxygenase (IDO) expression, in patients with metastatic melanoma who had been previously treated with antiCTLA-4 blocking antibodies (ipilimumab).